Previous studies demonstrated that etanercept decreased intraocular inflammation in a rat model of uveitis and prevented retinal ganglion cell loss in a rat model of glaucoma by reducing the TNF-α level [11, 15]. This evidence concerns the gene TNF and glaucoma.